Fort Collins, CO, United States of America

Rajan Bawa


 

Average Co-Inventor Count = 3.3

ph-index = 4

Forward Citations = 173(Granted Patents)


Location History:

  • Fort Worth, TX (US) (1996)
  • Fort Collins, CO (US) (2000 - 2001)

Company Filing History:


Years Active: 1996-2001

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations in Ophthalmic Drug Delivery: The Work of Rajan Bawa

Introduction

Rajan Bawa, based in Fort Collins, Colorado, has made significant contributions to the field of ophthalmic drug delivery systems. With a total of four patents to his name, Bawa's work is focused on developing innovative solutions that enhance the comfort and effectiveness of ocular medications.

Latest Patents

Among Bawa's latest patents is a groundbreaking approach to gelling ophthalmic compositions containing xanthan gum. These ophthalmic drug delivery vehicles are designed to be administered as a liquid, which then gels upon contact with the eye. This innovative formulation not only improves the delivery of medications but also includes an ophthalmically acceptable anesthetic agent, making it more comfortable for the user. The dual benefits of xanthan gum in these compositions represent a significant advancement in ophthalmic therapy.

Career Highlights

Throughout his career, Rajan Bawa has worked with reputed companies such as Alcon Laboratories, Inc. and Alcon Manufacturing, Ltd. His roles in these organizations have allowed him to be at the forefront of ocular drug delivery innovations, demonstrating a commitment to enhancing patient care through improved medication delivery systems.

Collaborations

Rajan has collaborated with notable individuals in his field, including Rex E Hall and Bhagwati P Kabra. These partnerships have fostered a creative exchange of ideas and expertise, contributing to the successful development and patenting of his ophthalmic inventions.

Conclusion

Rajan Bawa's work continues to have a profound impact on the field of ophthalmology. His inventions not only advance the delivery of drug therapies but also enhance patient comfort and accessibility. With a focus on innovation and collaboration, Bawa remains a significant figure in ophthalmic research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…